RE:RE:RE:RE:level 2 fredgoodwinson wrote: Had some more meself today Tom - only bothered about what 'the market' thinks the stock is worth in so much as it might restrict the Company`s ability to run the Trials (another one coming up soon?) and this looks less and less likely to be the case especially if there`s life in MaRs.
Comfortably in the green now and the Clock has been started.Much to look forward to here I think.
If you`re only wondering whether Joe is too negative you should have been here the last 5 years`!
Every investor from the time they take a position in a stock then thinks its sp will go to the moon. Many of us make the mistake of jumping in based on hype alone thinking the sp has nowhere to go but up. It's one thing to feel confident about the stock but quite another to deny to oneself what the company is actually saying in its PRs. The smart investors don't rely on a SH board to form their appraisal of a stock but they comb through company NRs for relevant information to base their financial position on. If TLT management thought the full complement of patients allocated to the Canadian wing of the phase 2 trial would begin their treatment in a short 2 or 3 weeks then I feel they would have said so in their PR. Some investors just refuse to accept that with all the protocols clinical trials must meet they by necessity are conducted in a slow and methodical way. Just ask Macer.